Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board
Digital Health Global
JUNE 20, 2023
These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,
Let's personalize your content